Contact Us | Find An Expert

Find an Expert
a

The Spokesman-Review (Spokane, Washington): Local Optometrist Treating Glaucoma Becomes Patient, Implanted with iStent inject® W

Apr 19, 2022 | Blog

“[Dr. Kordish] was on three previous medications for glaucoma, and luckily we were able to get him off all three, which makes your eye a lot more comfortable. The cost of drops and the cumbersome nature of putting them in every day; it’s a big advantage not to have to do that anymore.”– Dr. Jonathan Haymore, MultiCare Rockwood Eye and Optical Center

As an optometrist, Dr. David Kordish has treated patients with glaucoma and cataracts for years. Then when he began experiencing his own vision issues, he found himself in the patient’s seat. Diagnosed with both cataracts and glaucoma, Dr. Kordish knew he needed to treat his conditions to prevent any additional vision loss.

Prior to cataract surgery, Dr. Kordish had been managing his glaucoma with multiple daily eye drops. However, he was in search of another treatment for his condition, as the drops irritated his eyes. At the recommendation of his ophthalmologist, Dr. Jonathan Haymore of MultiCare Rockwood Eye and Optical Center, Dr. Kordish was implanted with the iStent inject® W during cataract surgery in both eyes. The iStent inject® W is a tiny implant that can help lower pressure in the eye, potentially reducing or eliminating the need for medication, like daily eye drops, at the discretion of a physician. 

Following the procedure, Dr. Kordish has been able to stop using all three of his daily glaucoma medications. Now that his condition has been treated, he is once again able to focus on his work at Brisbane Eyecare in Spokane Valley, where he continues to help patients with glaucoma and cataracts. Only now, he can recommend specific treatments from firsthand experience. 

Dr. Kordish and Dr. Haymore recently spoke with The Spokesman-Review to discuss Dr. Kordish’s journey with glaucoma and the importance of seeking timely treatment. You can check out the full story here.

For more information on glaucoma or to read similar experiences like Dr. Kordish, visit our website. 

 

Speak With a Physician About iStent Today

Help is right around the corner. Leading ophthalmologists across the country offer iStent® technology, including the most recently FDA-approved iStent inject® W, designed to help reduce intraocular pressure in patients undergoing concurrent cataract surgery. Find out if you are a candidate for iStent inject® W by speaking with a trained physician in your area today.

Locate an iStent physician near you: https://www.glaukos.com/contact-a-physician/

The results described on this site are based on data collected regarding short- and intermediate-term efficacy of treatment. Individual results are not guaranteed and may vary. For more information, visit: https://www.glaukos.com/important-safety-information/istent-inject-w/.

 

PM-US-0875

Hear from Others with Glaucoma

View Stories

Recent Blog Posts

Dry Eye & Glaucoma: What You Need to Know

Dry Eye & Glaucoma: What You Need to Know

Sep 23, 2022 |

Millions of Americans report having symptoms of dry eye, but did you know that dry eye and glaucoma often occur together? In this blog, we’re talking about the connection between dry eye and glaucoma, as well as some causes and treatment options to consider.

Stay Connected

Sign up to receive the latest information about glaucoma, new treatments, research findings and more!

Glaukos will use the information you provide on this form to be in touch with you.

Consent(Required)
This field is for validation purposes and should be left unchanged.

INDICATION FOR USE
The iStent inject® W Trabecular Micro-Bypass System Model G2-W is indicated for use in conjunction with cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild-to-moderate primary open-angle glaucoma.

CONTRAINDICATIONS
The iStent inject® W is contraindicated in eyes with angle-closure glaucoma, traumatic, malignant, uveitic, or neovascular glaucoma, discernible congenital anomalies of the anterior chamber (AC) angle, retrobulbar tumor, thyroid eye disease, or Sturge-Weber Syndrome or any other type of condition that may cause elevated episcleral venous pressure.

WARNINGS
Gonioscopy should be performed prior to surgery to exclude congenital anomalies of the angle, PAS, rubeosis, or conditions that would prohibit adequate visualization of the angle that could lead to improper placement of the stent and pose a hazard.

MRI INFORMATION
The iStent inject® W is MR-Conditional, i.e., the device is safe for use in a specified MR environment under specified conditions; please see Directions for Use (DFU) label for details.

PRECAUTIONS
The surgeon should monitor the patient postoperatively for proper maintenance of intraocular pressure (IOP). The safety and effectiveness of the iStent inject® W have not been established as an alternative to the primary treatment of glaucoma with medications, in children, in eyes with significant prior trauma, abnormal anterior segment, chronic inflammation, prior glaucoma surgery (except SLT performed > 90 days preoperative), glaucoma associated with vascular disorders, pseudoexfoliative, pigmentary or other secondary open-angle glaucomas, pseudophakic eyes, phakic eyes without concomitant cataract surgery or with complicated cataract surgery, eyes with medicated intraocular pressure (IOP) > 24 mmHg or unmedicated intraocular pressure (IOP) < 21 mmHg or > 36 mmHg, or for implantation of more or less than two stents.

ADVERSE EVENTS
Common postoperative adverse events reported in the iStent inject® randomized pivotal trial included stent obstruction (6.2%), intraocular inflammation (5.7% for iStent inject® vs. 4.2% for cataract surgery only), secondary surgical intervention (5.4% vs. 5.0%) and BCVA loss ≥ 2 lines ≥ 3 months (2.6% vs. 4.2%).

CAUTION
Federal law restricts this device to sale by, or on the order of, a physician. Please see DFU for a complete list of contraindications, warnings, precautions, and adverse events.

Text Optimizer
Share This